trending Market Intelligence /marketintelligence/en/news-insights/trending/MRnKpP2Zidr-bn8UbMYBmA2 content esgSubNav
In This List

AzurRx appoints board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


AzurRx appoints board member

AzurRx BioPharma Inc. appointed Vern Lee Schramm to its board.

A frequent lecturer and presenter in topics related to chemical biology, Schramm has been a consultant and advisor to Pico Pharmaceuticals, Metabalon Biochemistry, Sirtris Scientific and BioCryst Pharmaceuticals Inc.